Imipenem, Cilastatin, Relebactam Combination Approved To Treat Complicated UTI, Intra-Abdominal Infections - Infectious Disease Advisor

Imipenem, Cilastatin, Relebactam Combination Approved To Treat Complicated UTI, Intra-Abdominal Infections  Infectious Disease Advisor

The Food and Drug Administration (FDA) has approved Recarbrio (imipenem, cilastatin, relebactam; Merck) for the treatment of adult patients aged 18 years and ...



Comments

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Symtuza: Uses, side effects, alternatives, and more - Medical News Today